Edition:
India

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

37.16USD
16 Nov 2018
Change (% chg)

$0.77 (+2.12%)
Prev Close
$36.39
Open
$35.64
Day's High
$37.34
Day's Low
$35.64
Volume
203,083
Avg. Vol
278,220
52-wk High
$73.90
52-wk Low
$17.40

Select another date:

Tue, Jul 17 2018

CRISPR gene editing can cause risky collateral DNA damage - study

LONDON Scientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause unexpected genetic damage which could lead to dangerous changes in some cells.

CRISPR gene editing can cause risky collateral DNA damage: study

LONDON Scientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause unexpected genetic damage which could lead to dangerous changes in some cells.

UPDATE 2-CRISPR gene editing can cause risky collateral DNA damage - study

LONDON, July 16 Scientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause unexpected genetic damage which could lead to dangerous changes in some cells.

Select another date: